Adicet Bio logo

Adicet Bio

ACET | NASDAQ
Chart Builder DCF Calculator
$2.75
-$0.03 (-1.08%)
At close: Nov 16, 2026, 4:00 PM ET
$2.75
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.08%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
33
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #710/1021 (Top 70%)

Key Statistics

Market Data

Market Cap $29.55M
1D Range
2.60 2.88
52W Range
2.60 10.37

Valuation (TTM)

PE -0.32
PB 0.29
EV/EBITDA 0.68

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $27.00
Loading financial charts...

Profile

Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The company’s strategy involves engineering...

Sector Healthcare
Industry Biotechnology
Employees 102
IPO Date Jan 26, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$27.00
Upside
+881.82%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.